(NOVO-B) Novo Nordisk - Performance -50.8% in 12m
Compare NOVO-B with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
43.95%
#12 in Group
Rel. Strength
10.76%
#7122 in Universe
Total Return 12m
-50.80%
#116 in Group
Total Return 5y
118.73%
#20 in Group
P/E 17.2
55th Percentile in Group
P/E Forward 14.2
54th Percentile in Group
PEG 0.88
79th Percentile in Group
FCF Yield 3.60%
91th Percentile in Group
12m Total Return: NOVO-B (-50.8%) vs XBI (-1.8%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: NOVO-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NOVO-B
Total Return (including Dividends) | NOVO-B | XBI | S&P 500 |
---|---|---|---|
1 Month | -7.39% | 2.28% | -0.87% |
3 Months | -27.16% | -10.48% | -7.58% |
12 Months | -50.80% | -1.83% | 11.88% |
5 Years | 118.73% | -12.72% | 110.33% |
Trend Score (consistency of price movement) | NOVO-B | XBI | S&P 500 |
1 Month | -64.6% | 56.6% | 23% |
3 Months | -86.3% | -89.3% | -88.5% |
12 Months | -93.3% | -42.4% | 55.1% |
5 Years | 93.1% | -53.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #152 | -9.45% | -6.58% |
3 Month | #127 | -18.6% | -21.2% |
12 Month | #115 | -49.9% | -56.0% |
5 Years | #19 | 151% | 3.99% |
FAQs
Does NOVO-B Novo Nordisk outperforms the market?
No,
over the last 12 months NOVO-B made -50.80%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months NOVO-B made -27.16%, while XBI made -10.48%.
Over the last 3 months NOVO-B made -27.16%, while XBI made -10.48%.
Performance Comparison NOVO-B vs Indeces and Sectors
NOVO-B vs. Indices NOVO-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 2.84% | -6.52% | -40.2% | -62.7% |
US NASDAQ 100 | QQQ | 1.81% | -8.79% | -40.6% | -63.5% |
US Dow Jones Industrial 30 | DIA | 3.78% | -4.21% | -40.1% | -60.0% |
German DAX 40 | DAX | 4.07% | -8.71% | -59.7% | -75.5% |
Shanghai Shenzhen CSI 300 | CSI 300 | 6.80% | -4.57% | -37.2% | -56.8% |
Hongkong Hang Seng | HSI | 3.83% | -7.45% | -42.1% | -64.7% |
India NIFTY 50 | INDA | 5.68% | -11.5% | -40.5% | -53.9% |
Brasil Bovespa | EWZ | 3.64% | -12.0% | -43.9% | -45.0% |
NOVO-B vs. Sectors NOVO-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 2.59% | -6.34% | -46.3% | -74.8% |
Consumer Discretionary | XLY | 2.76% | -7.29% | -42.7% | -64.1% |
Consumer Staples | XLP | 6.34% | -7.59% | -45.5% | -62.0% |
Energy | XLE | 7.32% | 6.47% | -34.4% | -39.7% |
Financial | XLF | 4.23% | -5.28% | -47.8% | -73.5% |
Health Care | XLV | 2.92% | -3.60% | -38.5% | -52.5% |
Industrial | XLI | 2.42% | -7.50% | -40.9% | -60.4% |
Materials | XLB | 3.45% | -4.96% | -32.8% | -47.3% |
Real Estate | XLRE | 4.36% | -6.08% | -39.3% | -68.9% |
Technology | XLK | 0.39% | -9.08% | -36.8% | -58.5% |
Utilities | XLU | 5.68% | -7.45% | -42.3% | -72.6% |
Aerospace & Defense | XAR | 1.89% | -13.8% | -53.7% | -77.4% |
Biotech | XBI | 1.54% | -9.67% | -27.5% | -49.0% |
Homebuilder | XHB | 3.53% | -5.12% | -25.4% | -43.8% |
Retail | XRT | 4.41% | -6.83% | -34.6% | -48.1% |